Carcinogenesis Mechanisms for the Involvement of DNA Methylation in Colon Updated

C —¿ > T transitions at CpG sites are the most prevalent mutations found in the p53 tumor suppressor gene in human colon tumors and in the germline (Li-Fraumeni syndrome). All of the mutational hot spots are methylated to 5-methylcytosine, and it has been hypothesized that the majority of these mutations are caused by spontaneous hydrolytic deamination of this base to thymine. We have previously reported that bacterial methyltransferases induce transition mutations at CpG sites by increasing the deamination rate of C —¿ » U when the concentration of the methyl group donor S-adenosylmethionine (AdoMet) drops below its A1M, suggest ing an alternative mechanism to create these mutations. Unrepaired uracil pairs with adenine during replication, completing the ( ' —¿ • T transition mutation. To determine whether this mechanism could contribute to the development of human colon cancer, we examined the level of DNA (cytosine-S)-methyltransferase (MTase) expression, the concentration of AdoMet, and the activity of uracil-DNA glycosylase in human colon tissues, and searched for the presence of mutations in the MTase gene. Using reverse transcription-PCR methods, we found that average MTase niKNA expression levels were only 3.7-fold elevated in tumor tissues compared with surrounding normal mucosa from the same patient. Also, no mutations were found in conserved regions of the gene in 10 tumors sequenced. High-performance liquid Chromatographie analysis of extracts from the same tissues showed that AdoMet concentrations were not reduced below the A,,, value for the mammalian enzyme, and the concen tration ratio of AdoMet:5-adenosylhomocysteine, the breakdown product of AdoMet and the competitive MTase inhibitor, did not differ signifi cantly. Finally, extracts from the tumor tissue efficiently removed uracil from DNA. Therefore, biochemical conditions favoring a mutagenic path way of C —¿ > U —¿ > T were not found in a target tissue known to undergo a high rate of C —¿ » T transitions at CpG sites.

[1]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[2]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[3]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[4]  R. Beart,et al.  Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors. , 1995, Cancer research.

[5]  A. Balmain Cancer: Exploring the bowels of DNA methylation , 1995, Current Biology.

[6]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[7]  L. Poirier,et al.  Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. , 1995, Cancer research.

[8]  R. Roberts,et al.  M.HhaI binds tightly to substrates containing mismatches at the target base. , 1995, Nucleic acids research.

[9]  A. Yang,et al.  HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. , 1995, Nucleic acids research.

[10]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[11]  S. Tornaletti,et al.  Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. , 1995, Oncogene.

[12]  E. Rimm,et al.  Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. , 1995, Journal of the National Cancer Institute.

[13]  Samuel H. Wilson,et al.  DNA Polymerase Conducts the Gap-filling Step in Uracil-initiated Base Excision Repair in a Bovine Testis Nuclear Extract (*) , 1995, The Journal of Biological Chemistry.

[14]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[15]  P. Jones,et al.  Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer , 1994, Molecular and cellular biology.

[16]  P. Jones,et al.  The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. , 1994, Nucleic acids research.

[17]  M. Wyszynski,et al.  Cytosine deaminations catalyzed by DNA cytosine methyltransferases are unlikely to be the major cause of mutational hot spots at sites of cytosine methylation in Escherichia coli. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Roberts,et al.  Hhal methyltransferase flips its target base out of the DNA helix , 1994, Cell.

[19]  Xiaodong Cheng,et al.  The DNA (cytosine-5) methyltransferases , 1994, Nucleic Acids Res..

[20]  M. Hollstein,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.

[21]  J. Herman,et al.  Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Baylin,et al.  Increased cytosine DNA-methyltransferase activity during colon cancer progression. , 1993, Journal of the National Cancer Institute.

[23]  B. Gostout,et al.  The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene , 1993, Human Genetics.

[24]  T. Lindahl Instability and decay of the primary structure of DNA , 1993, Nature.

[25]  N. Hayashi,et al.  Expression of DNA methyltransferase in LEC rats during hepatocarcinogenesis. , 1993, Carcinogenesis.

[26]  J. Christman,et al.  Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. , 1993, Carcinogenesis.

[27]  J. Locker,et al.  p53 mutations in hepatocellular carcinomas induced by a choline-devoid diet in male Fischer 344 rats. , 1993, Carcinogenesis.

[28]  Peter A. Jones,et al.  High frequency mutagenesis by a DNA methyltransferase , 1992, Cell.

[29]  A. Zauber,et al.  Precursors of colorectal carcinoma Biopsy and biologic markers , 1992, Cancer.

[30]  B. Trask,et al.  Isolation and characterization of the cDNA encoding human DNA methyltransferase. , 1992, Nucleic acids research.

[31]  A. Riggs,et al.  X-chromosome inactivation and cell memory. , 1992, Trends in genetics : TIG.

[32]  L. Poirier,et al.  Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. , 1992, Cancer research.

[33]  S. Baylin,et al.  Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Schorderet,et al.  Analysis of CpG suppression in methylated and nonmethylated species. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  William Arbuthnot Sir Lane,et al.  Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase. , 1991, Biochemistry.

[36]  H. Krokan,et al.  Cell cycle regulation and in vitro hybrid arrest analysis of the major human uracil-DNA glycosylase. , 1991, Nucleic acids research.

[37]  K. Bock,et al.  Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. , 1991, Biochemical pharmacology.

[38]  R. Cella,et al.  Purification and properties of a novel DNA methyltransferase from cultured rice cells. , 1991, Biochemical and biophysical research communications.

[39]  M. Bartolomei,et al.  Parental imprinting of the mouse H19 gene , 1991, Nature.

[40]  S. Baylin,et al.  High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.

[42]  A. Bird,et al.  The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  B. Horsthemke,et al.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma , 1989, Human Genetics.

[44]  P. Dudeja,et al.  1,2-Dimethylhydrazine-induced premalignant alterations in the S-adenosylmethionine/S-adenosylhomocysteine ratio and membrane lipid lateral diffusion of the rat distal colon. , 1988, Biochimica et biophysica acta.

[45]  S. Baylin,et al.  The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Poirier,et al.  c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. , 1988, Carcinogenesis.

[47]  M. Ehrlich,et al.  Repair of thymine.guanine and uracil.guanine mismatched base-pairs in bacteriophage M13mp18 DNA heteroduplexes. , 1987, Journal of molecular biology.

[48]  H. Follmann,et al.  DNA methylation in wheat. Purification and properties of DNA methyltransferase. , 1987, European journal of biochemistry.

[49]  M. Foster,et al.  Hydration, volume changes and nuclear magnetic resonance proton relaxation times of HeLa S-3 cells in M-phase and the subsequent cell cycle. , 1987, Journal of cell science.

[50]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[51]  D. Santi,et al.  Kinetic and catalytic mechanism of HhaI methyltransferase. , 1987, The Journal of biological chemistry.

[52]  R. Gupta,et al.  NMR measurement of intracellular water volume in rat kidney proximal tubules. , 1986, Biochimica et biophysica acta.

[53]  S. Baylin,et al.  DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. , 1986, Cancer research.

[54]  A. Bird CpG-rich islands and the function of DNA methylation , 1986, Nature.

[55]  P. Jones,et al.  DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. , 1986, The Journal of biological chemistry.

[56]  A. Niveleau,et al.  DNA methyltransferases in normal and avian sarcoma virus-transformed rat cells. Quantitation of 5-methyldeoxycytidine in DNA and enzyme kinetics study. , 1985, Biochimica et biophysica acta.

[57]  F. Becker,et al.  Indistinguishable physical and catalytic properties of DNA methyltransferase from normal rat liver and a transplantable rat hepatocellular carcinoma. , 1985, Carcinogenesis.

[58]  A. Feinberg,et al.  Hypomethylation of DNA from benign and malignant human colon neoplasms. , 1985, Science.

[59]  C. Danzin,et al.  A rapid high-performance liquid chromatographic procedure for the simultaneous determination of methionine, ethionine, S-adenosylmethionine, S-adenosylethionine, and the natural polyamines in rat tissues. , 1984, Analytical biochemistry.

[60]  K. Giercksky,et al.  Interindividual variation in the activity of O6-methyl guanine-DNA methyltransferase and uracil-DNA glycosylase in human organs. , 1983, Carcinogenesis.

[61]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[62]  D. Rowitch,et al.  Extent of DNA methylation in human tumor cells. , 1983, Journal of the National Cancer Institute.

[63]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[64]  M. Ehrlich,et al.  Heat- and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA. , 1982, Biochimica et biophysica acta.

[65]  Jeffrey H. Miller,et al.  Mutagenic deamination of cytosine residues in DNA , 1980, Nature.

[66]  Philip J. Farabaugh,et al.  Molecular basis of base substitution hotspots in Escherichia coli , 1978, Nature.

[67]  R. Mirimanoff,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1994, The New England journal of medicine.

[68]  Y. Weng,et al.  Developmental regulation of the base excision repair enzyme uracil DNA glycosylase in the rat. , 1993, Mutation research.

[69]  S. Baylin,et al.  Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. , 1991, Cancer cells.

[70]  J. Buckley,et al.  The role of DNA methylation in cancer. , 1990, Advances in cancer research.